Vorapaxar acts by inhibiting
Vorapaxar inhibits Protease Activated Receptor 1 (PAR1) which is a thrombin receptor and thus can be used as a antiplatelet drug in M.I
GPIIa / IIIb
P2Y12 receptor
PAR - 1
Antithrombin - 3